Clicky

Sartorius Stedim Biotech SA(56S1)

Description: Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.


Keywords: Chemical Biotechnology Pharmaceutical Life Sciences Gene Therapy Biological Products Biopharmaceutical Industry Biopharmaceutical Development Cell Culture Media Data Analytics Software Sartorius Ag Single Use Bioreactor Fluid Management Services Gene Therapy Applications Hollow Fiber Membrane Devices

Home Page: www.sartorius.com

Zone Industrielle Les Paluds
Aubagne, 13781
France
Phone: 33 4 42 84 56 00


Officers

Name Title
Dr. Joachim Kreuzburg Chairman & CEO
Mr. Heiko Imöhl VP of Group Financing & Investor Relations
Ms. Petra Kirchhoff Head of Corp. Communications & IR
Mr. John Gerard Mackay Exec. VP of Marketing, Sales & Services for Lab Products and Services Division
Benedikt Orzelek Head of Investor Relations
Olivier Guitard Head of Controlling BPS

Exchange: F

Country: DE

Currency: Euro (€)

Forward PE: 31.8471
Trailing PE: 42.4426
Price-to-Book MRQ: 13.1839
Price-to-Sales TTM: 8.622
IPO Date:
Fiscal Year End: December
Full Time Employees: 10409
Back to stocks